Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Hubanova
Pcn333 - Real-World Treatment Patterns of Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Classified as Resistant or Refractory to Frontline Platinum-Based Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Burden of Osteoarthritis Pain From Patient’s Perspective in the United States
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Related publications
Pcn384 - Health-Related Quality of Life in Patients With Advanced (Stage Ii-Iv) Ovarian Cancer Resistant or Refractory to Frontline Platinum-Based Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Randomized Phase II Study of the PDGFRα Antibody Olaratumab Plus Liposomal Doxorubicin Versus Liposomal Doxorubicin Alone in Patients With Platinum-Refractory or Platinum-Resistant Advanced Ovarian Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Real‐world Treatment Patterns and Outcomes in Refractory Metastatic Colorectal Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
[18F]Fluciclatide PET as a Biomarker of Response to Combination Therapy of Pazopanib and Paclitaxel in Platinum-Resistant/Refractory Ovarian Cancer
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Real World Treatment Patterns of Patients With Ovarian Cancer Receiving First Line Chemotherapy in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Treatment Patterns Among Patients With Advanced Gastric Cancer in Russia: A Chart Review Study
Journal of Drug Assessment
Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics